I'm LongbridgeAI, I can summarize articles.Sangrix restated its interim financials for the six months ended Dec. 31, 2025, due to material errors in share classification and warrant dividends. The company reclassified US$4.2 million of Class A ordinary shares from permanent to mezzanine equity and adjusted convertible debenture items. Consequently, the deemed dividend from warrant down-round features was reduced to US$7.73 million, increasing the attributable loss to US$16.4 million.
- Sangrix filed a Form 6-K/A restating interim financial statements for the six months ended Dec. 31, 2025. * Restatement deemed material under SEC Staff Accounting Bulletin No. 99. * Reclassified certain redeemable Class A ordinary shares from permanent equity to mezzanine equity, shifting US$ 4.2 million within equity. * Recast convertible debenture items under the fair value option; no change to consolidated net loss. * Reduced deemed dividend from warrant down-round features to US$ 7.73 million, lifting loss attributable to Sangrix to US$ 16.4 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sangrix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-108949), on September 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here